Prolonged Anticoagulant Remedy along with Full- as well as Reduced-Dose Proto-oncogene tyrosine-protein kinase Src within Patients with Cancer-Associated Venous Thromboembolism: the particular API-CAT Study. Website: https://www.selleckchem.com/products/incb28060.html